JPRN-UMIN000002207
Not yet recruiting
Phase 4
Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertension - Therapeutic efficacy of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist to patients with high risk hypertension
Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School0 sites40 target enrollmentJuly 22, 2009
ConditionsHypertension
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with hypersensitive history to olmesartan medoxomil, azelnidipine, valsartan and amlodipine besilate 2\. Pregnant women or women who have possibility of pregnancy 3\. Patients administrated with azole antifungal drug or protease inhibitor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Combination low dose blood pressure lowering treatment for patients with untreated hypertensioACTRN12617001533381George Medicines12
Completed
Not Applicable
Blood pressure lowering effect of one compound tablet replacement as two tablets of angiotensin 2 receptor blocker(ARB) and calcium channel blocker(CCB)the hypertensive patient who has taken ARB and CCBJPRN-UMIN000008360Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences200
Completed
Not Applicable
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.HypertensionJPRN-UMIN000011328Toshio Kushiro170
Not yet recruiting
Not Applicable
oninvasive cardiac output monitoring to optimise therapy for patients with poorly controlled hypertension: a randomised controlled trialHypertensionCardiovascular - HypertensionACTRN12611001289909The Chinese University of Hong Kong202
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60